CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate
  • #AACR16 Update: The Promise of Synthetic Biology and CAR T Cell Technologies

    Genetically engineered cells can be customized to target cancer.

    April 20, 2016| Arthur N. Brodsky, PhD
  • #AACR16 Update: The Cancer Research Institute’s Impact on Immunotherapy

    Since our founding in 1953, the Cancer Research Institute has pioneered the field of cancer immunology, and…
    April 20, 2016| Arthur N. Brodsky, PhD
  • #AACR16 Update: How Immune Infiltration Predicts Survival in Cancer Patients

    The Immunoscore is the strongest prognostic marker in colorectal cancer.

    April 19, 2016| Arthur N. Brodsky, PhD
  • #AACR16 Update: Combination Therapies to Improve Anti-cancer Immune Responses

    Complementary treatments can help overcome resistance to immunotherapy.

    April 18, 2016| Arthur N. Brodsky, PhD
  • #AACR16 Update: Engaging the Immune System to Treat Pancreatic Cancer

    Immunotherapy strategies to treat pancreatic cancer could also be effective in other difficult-to-treat cancers.

    April 18, 2016| Arthur N. Brodsky, PhD
  • #AACR16 Update: Checkpoint Inhibition and Improving Anti-Tumor Immunity

    Releasing the brakes on the immune system to overcome cancer

    April 17, 2016| Arthur N. Brodsky, PhD
  • #AACR16 Update: Deciphering the Cancer Genome & Developing Tailored Treatments

    To conquer cancer, scientists must first unmask its identity

    April 17, 2016| Arthur N. Brodsky, PhD
  • Immunotherapy’s Bright Future

    Tech entrepreneur Sean Parker bets big on immunotherapy.

    April 14, 2016| Arthur N. Brodsky, PhD
  • The History and Future of Cancer Immunotherapy

    The path to achieving immunotherapy’s full potential.

    March 17, 2016| Arthur N. Brodsky, PhD

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2026, Cancer Research Institute